Elcid Investments Unlisted Share

Overview

Elcid Investments Limited was incorporated on 3 December 1981 under the Companies Act 1956 in Mumbai. It is a Non-Banking Finance Company registered with the Reserve Bank of India. The company has two subsidiaries as of March 2019, namely, Suptaswar Investment and Trading Co. Ltd. and Murahar Investment and Trading Co. Ltd. These subsidiaries are also registered with the Reserve Bank Of India as Non-Banking Finance Companies. The Company majorly deals in business by investing in shares (listed and unlisted), debentures, mutual funds, and more.

Elcid Investments Limited's Unlisted Share Price are updated on our website on a daily basis, to stay updated with the share price you can visit our website every two days or register with us to get daily updates on WhatsApp.

Elcid Investments FAQ's

Yes trading in unlisted shares is undoubtedly legal in India. The trading takes place in the over-the-counter market through various platforms like www.pmsnstocks.com.

No, SEBI does not regulate the unlisted share market but certain rules and regulations of SEBI are applicable in the unlisted market space as well, such as, the DP charges for each transaction, stamp duty, lock-in period and more.

Over the years the minimum ticket size for investment has dropped as more and more people have started investing in the Unlisted market. Currently, the minimum ticket size for Elcid Investments is between 30K to 50K.

You can check daily share prices of companies on our website or register with us using your phone number where you will get daily whatsapp updates on company news and other essential informations.

Speak to Private Equity Consultant

Confused... How to Pick the Best Stock? Take Advice From Best Private Equity Advisors

Disclaimer: www.pmsnstocks.com is an information portal. www.pmsnstocks.com is not an investment advisory portal and does not make any investment recommendations
and therefore does not require any license from SEBI/RBI or regulatory authority in India.Investors are advised to use the data at their own risks.